Lumida
/UVV
⌘K
Universal Corp

Universal Corp

UVV
$53.14USD+0.23%+0.12 today

MARKET CAP

1.3B

P/E (TTM)

10.3x

FWD P/E

11.8x

DAY RANGE

$52 – $54

52W RANGE

$49
$59

AI Summary

Stalk
Buy NowMedium

UVV is forming an early Stage 1 base after prior weakness, and a recent Momentum Breakout above key EMAs signals bullish asymmetry for the medium term. Long-term trend remains up, while short-term price is tightly tracking rising 9 EMA/21 EMA without exhaustion, supporting immediate participation near the breakout pivot. The base is fragile, so execution at this structural support zone is advised.

  • 56th consecutive dividend increase with 0.81% yield underscores cashflow
  • Book-to-price ratio of 0.99 and strong earnings yield support value thesis
  • Q4 net loss of $43m driven by $43m inventory write-downs
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Universal Corporation (NYSE: UVV) is a dominant player in the global tobacco industry, focusing on the procurement, processing, and sale of leaf tobacco while also expanding into the food ingredients sector. With a robust heritage of over 100 years, it has adapted well to market fluctuations and is progressively innovating its ingredients business to meet evolving consumer preferences, especially for clean label and organic products. The company seeks to leverage its extensive global footprint and established customer relationships to navigate challenges, such as market oversupply and inflationary pressures.

Bull says

  • 56th consecutive dividend increase with 0.81% yield underscores cashflow
  • Book-to-price ratio of 0.99 and strong earnings yield support value thesis
  • Pivot to organic food ingredients aligns with shifting consumer preferences
  • Management targets uncommitted inventory of 10–20% by FY27 to improve efficiency
  • Positive momentum indicators suggest share price resilience amid market recovery
  • Global footprint and long history enhance adaptability to complex markets

Bear says

  • Q4 net loss of $43m driven by $43m inventory write-downs
  • Net debt of $845m elevates leverage and financial strain
  • Operating loss of $15m in Q4 vs $43m income year-ago
  • Ingredients revenue fell 8% YoY to $83m, reflecting segment weakness
  • Weak profitability and quality metrics flag balance sheet vulnerabilities
  • High share price volatility and limited institutional backing weigh on sentiment

Investment themes with UVV

High Dividend Yield +0.32%

Companies paying above-average dividends

AVGO · JPM · XOM

Earnings Call · Q1 2025 · Mgmt. Guidance

Updated 06-01-2026bullish

Transcript signals

Bull points

  • $597.1 million, up approximately 15% for both our tobacco and ingredient operations segments, while operating income was $17.2 million, up $6.2 million, or 56%, compared to the same quarter last fiscal year.
  • We believe this demand will continue to support solid results for the segment for fiscal year 2025.
  • Our strategic decisions to accelerate tobacco crop purchasing allowed us to secure our contracted tobacco in certain dynamic markets, which has positioned us well to meet customer demand.

Bear points

  • As expected, our debt level remained elevated at June 30, 2024.
Read full transcript analysis ›